Evidence map›Paper›PMID 37223734›Full record

ArticlemicroLife2023

From an Hsp90 - binding protein to a peptide drug.

Aparna Viswanathan Ammanath, Anders Jarneborn, Minh-Thu Nguyen, Laura Wessling, Paula Tribelli, Mulugeta Nega, Christian Beck, Arif Luqman, Khaled A Selim, Hubert Kalbacher and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in microLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Aparna Viswanathan AmmanathMicrobial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0001-9602-3757
Anders JarnebornDepartment of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden.
Minh-Thu NguyenSection of Medical and Geographical Infectiology, Institute of Medical Microbiology, University Hospital of Münster, Münster 48149, Germany.
Laura WesslingDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomik and ICePhA, University of Tuebingen, Tuebingen 72074, Germany.
Paula TribelliDepartamento de Química Biológica, FCEyN-UBA, IQUIBICEN, Ciudad Autónoma de Buenos Aires, CP1428EGA, Argentina.
Mulugeta NegaMicrobial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen 72076, Germany.
Christian BeckInfection Biology, Interfaculty Institute for Microbiology and Infection Medicine Tübingen, University of Tübingen, Tübingen 72076, Germany.
Arif LuqmanBiology Department, Institut Teknologi Sepuluh Nopember, Surabaya 60111, Indonesia.
Khaled A SelimOrganismic Interactions Department, Interfaculty Institute for Microbiology and Infection Medicine, University of Tübingen, Tübingen 72076, Germany.
Hubert KalbacherInterfacultary Institute for Biochemistry, University of Tübingen, Tübingen 72076, Germany.
Boris MacekProteome Center Tübingen, University of Tübingen, Tübingen 72076, Germany.
Sandra Beer HammerDepartment of Pharmacology, Experimental Therapy and Toxicology, Institute of Experimental and Clinical Pharmacology and Pharmacogenomik and ICePhA, University of Tuebingen, Tuebingen 72074, Germany.
Tao JinDepartment of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41346, Sweden.
Friedrich GötzMicrobial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen 72076, Germany.ORCID https://orcid.org/0000-0002-2042-0518
University of Tübingen · DEUniversity of Gothenburg · SEInstituto de Química y Fisicoquímica Biológicas · ARSepuluh Nopember Institute of Technology · IDUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Lpl proteins represent a class of lipoproteins that was first described in the opportunistic bacterial pathogen

Indexed as

Hsp90-interactioninfectionlarvae/mouse Infection modelLpl-derived peptidesStaphylococcus aureus

Identifiers

PMID37223734
PMCPMC10117725
OpenAlexW4311277689

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.